[HTML][HTML] p53 signaling in cancer progression and therapy

HE Marei, A Althani, N Afifi, A Hasan, T Caceci… - Cancer cell …, 2021 - Springer
The p53 protein is a transcription factor known as the" guardian of the genome" because of
its critical function in preserving genomic integrity. The TP53 gene is mutated in …

Mutant P53 in the formation and progression of the tumor microenvironment: friend or foe

ER Asl, D Rostamzadeh, PHG Duijf, S Mafi, B Mansoori… - Life sciences, 2023 - Elsevier
TP53 is the most frequently mutated gene in human cancer. It encodes the tumor suppressor
protein p53, which suppresses tumorigenesis by acting as a critical transcription factor that …

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

ZA Ely, N Mathey-Andrews, S Naranjo, SI Gould… - Nature …, 2024 - nature.com
Genetically engineered mouse models only capture a small fraction of the genetic lesions
that drive human cancer. Current CRISPR–Cas9 models can expand this fraction but are …

TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma

M Pan, C Jiang, Z Zhang, N Achacoso… - JCO Precision …, 2023 - ascopubs.org
PURPOSE To examine the impact of TP53 gain-of-function (GOF) and non-GOF mutations
on prognosis of advanced pancreatic ductal adenocarcinoma (PDAC) among patients with …

[HTML][HTML] Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis

E Pavlakis, M Neumann, N Merle, R Wieboldt… - Journal of Experimental …, 2023 - Springer
Background TP53, encoding the tumor suppressor p53, is frequently mutated in various
cancers, producing mutant p53 proteins (mutp53) which can exhibit neomorphic, gain-of …

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins

S Mukherjee, M Maddalena, YQ Lü… - Proceedings of the …, 2022 - National Acad Sciences
Missense mutations in the p53 tumor suppressor abound in human cancer. Common
(“hotspot”) mutations endow mutant p53 (mutp53) proteins with oncogenic gain of function …

Potential role of Marine Bioactive Compounds in cancer signaling pathways: A review

S Manoharan, E Perumal - European Journal of Pharmacology, 2022 - Elsevier
Cancer is characterized by alterations that cause the over-proliferation of cells and
hyperactivation of signaling pathways. Alterations of signaling molecules dysregulate …

[HTML][HTML] Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells

T Madrigal, D Ortega-Bernal, LA Herrera… - Cells, 2023 - mdpi.com
The master-key TP53 gene is a tumor suppressor that is mutated in more than 50% of
human cancers. Some p53 mutants lose their tumor suppressor activity and acquire new …

[HTML][HTML] Targeting oncogenic pathways in the era of personalized oncology: a systemic analysis reveals highly mutated signaling pathways in cancer patients and …

A Karagiannakos, M Adamaki, A Tsintarakis… - Cancers, 2022 - mdpi.com
Simple Summary Currently, genomic databases offer a vast amount of information on
mutational profiles and records of statistically significant genetic associations with diseases …

Lead intoxication‐induced exosomes promote autophagy and apoptosis in renal proximal tubule cells by activating the adenosine 5'‐monophosphate‐activated …

Q Jiang, X Feng, J Shen, Y Wang… - Environmental …, 2023 - Wiley Online Library
Lead (Pb) intoxication is known to damage the proximal tubules of kidney. Autophagy and
apoptosis have been shown to be involved in a variety of renal injuries, but the underlying …